Dendritic cells and immunotherapy for cancer Journal Article


Authors: Chang, D. H.; Dhodapkar, M. V.
Article Title: Dendritic cells and immunotherapy for cancer
Abstract: Dendritic cells, nature's adjuvant, are antigen-presenting cells specialized to initiate and regulate immunity. Their potent antigen-presenting function has encouraged targeting of dendritic cells (DCs) for harnessing the immune system against cancer. DCs are efficient at activating not only CD4+ helper T-cells and CD8+ killer T-cells but also B-cells and innate effectors such as natural killer and natural killer T-cells. Early studies of adoptive transfer of tumor antigen-loaded DCs have shown promise. However, DC vaccination is at an early stage, and several parameters still need to be established. The complexity of the DC system brings about the necessity for its rational manipulation for achieving protective and therapeutic immunity in patients. © 2003 The Japanese Society of Hematology.
Keywords: review; nonhuman; dendritic cell; b lymphocyte; immunoregulation; antigen presentation; dendritic cells; immunotherapy; cancer vaccines; cytotoxic t lymphocyte; natural killer cell; tumor vaccine; adoptive immunotherapy; antigen presenting cell; t lymphocyte subpopulation; immunotherapy, adoptive; helper cell; t-cells; cancer; humans; human
Journal Title: International Journal of Hematology
Volume: 77
Issue: 5
ISSN: 0925-5710
Publisher: Springer Japan KK  
Date Published: 2003-06-01
Start Page: 439
End Page: 443
Language: English
PUBMED: 12841381
PROVIDER: scopus
DOI: 10.1007/BF02986611
DOI/URL:
Notes: Export Date: 25 September 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors